0.0250
+0.0100
+(66.67%)
At close: January 10 at 2:05:06 PM EST
Breakdown
TTM
1/31/2024
1/31/2023
1/31/2022
1/31/2021
Operating Cash Flow
-153.0000
-1,009.0000
-3,197.0000
-3,220.0000
-2,981.0000
Investing Cash Flow
--
--
--
-33.0000
-3.0000
Financing Cash Flow
75.0000
937.0000
2,945.0000
1,164.0000
5,051.0000
End Cash Position
33.0000
35.0000
108.0000
313.0000
2,379.0000
Capital Expenditure
--
--
--
-33.0000
-3.0000
Issuance of Capital Stock
937.0000
937.0000
2,702.0000
--
2,467.0000
Issuance of Debt
--
--
--
1,027.0000
3,433.0000
Repayment of Debt
--
--
-375.0000
--
-768.0000
Free Cash Flow
-153.0000
-1,009.0000
-3,197.0000
-3,253.0000
-2,984.0000
1/31/2021 - 10/10/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
QPTFF Quest PharmaTech Inc.
0.0133
0.00%
QRON Qrons Inc.
0.1830
0.00%
GTTX.CN GeneTether Therapeutics Inc.
0.1200
0.00%
WBIO.CN WPD Pharmaceuticals Inc.
0.1900
0.00%
QPT.V Quest PharmaTech Inc.
0.0250
0.00%
DOSE.CN Rapid Dose Therapeutics Corp.
0.2250
-6.25%
SEOVF Sernova Corp.
0.1500
0.00%
AMBS Amarantus BioScience Holdings, Inc.
0.0001
0.00%
MBIO.CN MindBio Therapeutics Corp.
0.0200
0.00%
MSCLF Satellos Bioscience Inc.
0.5990
0.00%